-
Esperion Therapeutics (NASDAQ:ESPR) Receives "Buy" Rating from HC Wainwright
来源: Buzz FX / 21 3月 2025 12:06:17 America/New_York
Esperion Therapeutics (NASDAQ:ESPR) Receives "Buy" Rating from HC Wainwright Written by MarketBeat March 21, 2025 Share Link copied to clipboard. Remove Ads Esperion Therapeutics ( NASDAQ:ESPR - Get Free Report ) 's stock had its "buy" rati
Read more...